219 related articles for article (PubMed ID: 35435626)
1. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
4. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
5. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
6. A novel risk score model based on glycolysis-related genes and a prognostic model for predicting overall survival of osteosarcoma patients.
Chen W; Lin Y; Huang J; Yan Z; Cao H
J Orthop Res; 2022 Oct; 40(10):2372-2381. PubMed ID: 34997639
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-related genes-based prognostic signature for osteosarcoma.
Yang F; Zhang Y
Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
[TBL] [Abstract][Full Text] [Related]
8. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
10. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
11. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
12. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients.
Yang M; Ma X; Wang Z; Zhang T; Hua Y; Cai Z
Aging (Albany NY); 2021 May; 13(9):12896-12918. PubMed ID: 33952718
[TBL] [Abstract][Full Text] [Related]
15. A five ferroptosis-related genes risk score for prognostic prediction of osteosarcoma.
Ge Z; Song D
Medicine (Baltimore); 2022 Dec; 101(50):e32083. PubMed ID: 36550843
[TBL] [Abstract][Full Text] [Related]
16. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
Front Immunol; 2022; 13():992266. PubMed ID: 36405691
[TBL] [Abstract][Full Text] [Related]
17. Construction of a prognostic risk score model based on the ARHGAP family to predict the survival of osteosarcoma.
Liu W; Xia K; Zheng D; Huang X; Wei Z; Wei Z; Guo W
BMC Cancer; 2023 Dec; 23(1):1179. PubMed ID: 38041020
[TBL] [Abstract][Full Text] [Related]
18. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
19. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
Chen S; Zeng J; Huang L; Peng Y; Yan Z; Zhang A; Zhao X; Li J; Zhou Z; Wang S; Jing S; Hu M; Li Y; Wang D; Wang W; Yu H; Miao J; Li J; Deng Y; Li Y; Liu T; Xu D
J Transl Med; 2022 May; 20(1):228. PubMed ID: 35568866
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
